Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-Generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/38iC0CH
via IFTTT